The neurochemistry of pediatric major depressive disorder: What do we know so far?

Psychiatric Times

Volumn 25, Issue 3, 2008, Pages

  Gabbay, Vilma ^a   Buchholz, Lucy ^a   Gonen, Oded ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42049087629     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety. 1998;7:3-14.
2. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA. 1999;281:1707-1713.
3. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med. 2001;7:541-547.
4. Danielsen EA, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker; 1999.
5. Christiansen P, Toft P, Larsson HB, et al. The concentration of N-acetyl aspartate, creatine + Phosphokreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging. 1993;11:799-806.
6. 1H NMR spectroscopic imaging. Magn Reson Med. 1990;13:62-76.
7. Duyn JH, Gillen J, Sobering G, et al. Multisection proton MR spectroscopic imaging of the brain. Radiology. 1993;188:277-282.
8. Duyn JH, Moonen CT. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med. 1993;30:409-414.
9. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 1994;117:49-58.
10. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37-45.
11. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport. 1991;2:131-134.
12. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278-285.
13. Loffelholz K, Klein J, Koppen A. Choline, a precursor of acetylcholine and phospholipids in the brain. Prog Brain Res. 1993;98:197-200.
14. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol. 1996;39:6-16.
15. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981-989.
16. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci. 2000;22:418-428.
17. Inglese M, Li BS, Rusinek H, et al. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med. 2003;50:190-195.
18. 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR. 2005;26:752-759.
19. Cecil KM. MR spectroscopy of metabolic disorders. Neuroimaging Clin N Am. 2006;16:87-116, viii.
20. Arnold DL, De Stefano N. Magnetic resonance spectroscopy in vivo: applications in neurological disordere. Ital J Neurol Sci. 1997;18:321-329.
21. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48:813-829.
22. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824-827.
23. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290-13295.
24. Mirza Y, Tang J, Russell A, et al. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry. 2004;43:341-348.
25. Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004;43:1146-1153.
26. Rosenberg DR, MacMaster FP, Mirza Y, et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58:700-704.
27. Farchione TR, Moore GJ, Rosenberg DR. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry. 2002;52:86-92.
28. Caetano SC, Fonseca M, Olvera RL, et al. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett. 2005;384:321-326.
29. Steingard RJ, Yurgelun-Todd DA, Hennen J, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000;48:1053-1061.
30. MacMaster FP, Kusumakar V. Choline in pediatric depression. McGill J Med. 2006:24-27.
31. Kusumakar V, MacMaster FP, Gates L, et al. Left medial temporal cytosolic choline in early onset depression. Can J Psychiatry. 2001;46:959-964.
32. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997;9:471-481.
33. Tremblay LK, Naranjo CA, Graham SJ, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry. 2005;62:1228-1236.
34. Lacerda AL, Nicoletti MA, Brambilla P, et al. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res. 2003;124:129-140.
35. Smith EA, Russell A, Lorch E, et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry. 2003;54:1399-1405.
36. Mirza Y, O'Neill J, Smith EA, et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol. 2006;21:106-111.
37. Gabbay V, Broody R, Nishawala M, et al. Proton magnetic resonance spectroscopy in adolescents with major depressive disorder. Presented at: American Academy of Child and Adolescent Psychiatry 53rd Annual Meeting; October 24-29,2006; San Diego.
38. Vataja R, Leppavuori A, Pohjasvaara T, et al. Post-stroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci. 2004;16:156-162.
39. Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry. 2004;55:563-569.
40. Exton JH. Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990;265:1-4.
41. Exton JH. Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta. 1994;1212:26-42.
42. Manji HK, Chen G. Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders. Curr Psychiatry Rep. 2000;2:479-489.